Definium Therapeutics, Inc.: current_liabilities
| Value | {"amount": 10559000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | Definium Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/11fa6862-e13e-44a3-bba6-da46bba1b453
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-009955 · Open the official SEC filing →Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001813814/current-liabilities/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/11fa6862-e13e-44a3-bba6-da46bba1b453
History
- no predecessors — first report